At a molecular level, there is an interaction between COVID-19 and PE, characterized by altered levels of angiogenic markers soluble fms-like tyrosine kinase (sFlt-1) and placental growth factor (PlGF) and higher sFlt-1/PlGF ratio (6, 11–13). The gene discussed is PGF; the disease is COVID-19.